{"id":"https://openalex.org/W4391096741","doi":"https://doi.org/10.1200/jco.2024.42.3_suppl.308","title":"Abemaciclib in patients (pts) with esophageal cancer (EC) with CDKN2A loss or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.","display_name":"Abemaciclib in patients (pts) with esophageal cancer (EC) with CDKN2A loss or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.","publication_year":2024,"publication_date":"2024-01-20","ids":{"openalex":"https://openalex.org/W4391096741","doi":"https://doi.org/10.1200/jco.2024.42.3_suppl.308"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.3_suppl.308","doi":"https://doi.org/10.1200/jco.2024.42.3_suppl.308","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.3_suppl.308","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062252471","display_name":"Tareq Al Baghdadi","orcid":"https://orcid.org/0009-0004-4690-669X","observed_orcids":["https://orcid.org/0009-0004-4690-669X"]},"institutions":[{"id":"https://openalex.org/I4210119866","display_name":"Michigan Cancer Research Consortium","ror":"https://ror.org/02mfxyv79","country_code":"US","type":"other","lineage":["https://openalex.org/I4210119866"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tareq Al Baghdadi","raw_affiliation_strings":["Michigan Cancer Research Consortium, IHA Hematology Oncology, Ypsilanti, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Michigan Cancer Research Consortium, IHA Hematology Oncology, Ypsilanti, MI","institution_ids":["https://openalex.org/I4210119866"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael Rothe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Rothe","raw_affiliation_strings":["American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058562764","display_name":"Pam K. Mangat","orcid":"https://orcid.org/0000-0001-8571-6742","observed_orcids":["https://orcid.org/0000-0001-8571-6742"]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pam K. Mangat","raw_affiliation_strings":["American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029296725","display_name":"Elizabeth S. Garrett-Mayer","orcid":"https://orcid.org/0000-0003-4709-0333","observed_orcids":["https://orcid.org/0000-0003-4709-0333"]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Garrett-Mayer","raw_affiliation_strings":["American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041306590","display_name":"Kathleen J. Yost","orcid":"https://orcid.org/0000-0002-9641-5627","observed_orcids":["https://orcid.org/0000-0002-9641-5627"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathleen J Yost","raw_affiliation_strings":["Cancer Research Consortium of West Michigan, Grand Rapids, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Consortium of West Michigan, Grand Rapids, MI","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110558137","display_name":"Vi Kien Chiu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104507","display_name":"Angeles Clinic and Research Institute","ror":"https://ror.org/01ct2ab72","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834","https://openalex.org/I4210104507"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vi Kien Chiu","raw_affiliation_strings":["The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, CA","institution_ids":["https://openalex.org/I4210104507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047690131","display_name":"Herbert Leon Duvivier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Herbert Leon Duvivier","raw_affiliation_strings":["City of Hope Atlanta, Newnan, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope Atlanta, Newnan, GA","institution_ids":["https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002575629","display_name":"Meredith Ann McKean","orcid":"https://orcid.org/0000-0003-0944-7418","observed_orcids":["https://orcid.org/0000-0003-0944-7418"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meredith McKean","raw_affiliation_strings":["Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN","institution_ids":["https://openalex.org/I4210100810","https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063403717","display_name":"Jens Rueter","orcid":"https://orcid.org/0000-0002-9021-025X","observed_orcids":["https://orcid.org/0000-0002-9021-025X"]},"institutions":[{"id":"https://openalex.org/I4210115256","display_name":"Jackson Laboratory","ror":"https://ror.org/021sy4w91","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210115256"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jens Rueter","raw_affiliation_strings":["The Jackson Laboratory, Brewer, ME"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jackson Laboratory, Brewer, ME","institution_ids":["https://openalex.org/I4210115256"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mark A. Taylor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145586","display_name":"Louisiana Cancer Research Center","ror":"https://ror.org/04f6dw135","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210145586"]},{"id":"https://openalex.org/I4210149244","display_name":"Swiss Cancer Center L\u00e9man","ror":"https://ror.org/03kwyfa97","country_code":"CH","type":"facility","lineage":["https://openalex.org/I114457229","https://openalex.org/I2802229882","https://openalex.org/I4210106256","https://openalex.org/I4210149244","https://openalex.org/I97565354"]}],"countries":["CH","US"],"is_corresponding":false,"raw_author_name":"Mark A. Taylor","raw_affiliation_strings":["Lewis Cancer & Research Pavilion, Savannah, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lewis Cancer & Research Pavilion, Savannah, GA","institution_ids":["https://openalex.org/I4210145586","https://openalex.org/I4210149244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078986413","display_name":"Gina N. Grantham","orcid":"https://orcid.org/0000-0002-3111-0419","observed_orcids":["https://orcid.org/0000-0002-3111-0419"]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gina N. Grantham","raw_affiliation_strings":["American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111231540","display_name":"Abby Gregory","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abby Gregory","raw_affiliation_strings":["American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085149228","display_name":"Dominique C. Hinshaw","orcid":"https://orcid.org/0000-0002-2052-9484","observed_orcids":["https://orcid.org/0000-0002-2052-9484"]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dominique C. Hinshaw","raw_affiliation_strings":["American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053535513","display_name":"Susan Halabi","orcid":"https://orcid.org/0000-0003-4135-2777","observed_orcids":["https://orcid.org/0000-0003-4135-2777"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Halabi","raw_affiliation_strings":["Duke University Medical Center, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031299191","display_name":"Richard L. Schilsky","orcid":"https://orcid.org/0000-0003-4474-4303","observed_orcids":["https://orcid.org/0000-0003-4474-4303"]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard L. Schilsky","raw_affiliation_strings":["American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"3_suppl","first_page":"308","last_page":"308"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.7109000086784363,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.7109000086784363,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.2029999941587448,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.010400000028312206,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abemaciclib","display_name":"abemaciclib","score":0.996999979019165},{"id":"https://openalex.org/keywords/esophageal-cancer","display_name":"esophageal cancer","score":0.9789999723434448},{"id":"https://openalex.org/keywords/cdkn2a-loss","display_name":"CDKN2A loss","score":0.9559999704360962},{"id":"https://openalex.org/keywords/cdkn2a-mutation","display_name":"CDKN2A mutation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.49799999594688416},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5400000214576721},{"id":"https://openalex.org/keywords/disease-control-rate","display_name":"disease control rate","score":0.6809999942779541},{"id":"https://openalex.org/keywords/esophageal-squamous-cell-carcinoma","display_name":"esophageal squamous cell carcinoma","score":0.8370000123977661},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5419999957084656},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5049999952316284},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.656000018119812},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5170000195503235}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9196386933326721},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6724081635475159},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6216710209846497},{"id":"https://openalex.org/C2780265364","wikidata":"https://www.wikidata.org/wiki/Q5009957","display_name":"CDKN2A","level":3,"score":0.610100269317627},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5202942490577698},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5093058347702026},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4501884877681732},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41126811504364014},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3467503786087036},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.32259100675582886}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.3_suppl.308","doi":"https://doi.org/10.1200/jco.2024.42.3_suppl.308","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.3_suppl.308","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281959120","https://openalex.org/W2889755009","https://openalex.org/W2891150573","https://openalex.org/W2765287480","https://openalex.org/W4392813151","https://openalex.org/W4393988143","https://openalex.org/W7162543395","https://openalex.org/W7162581563","https://openalex.org/W2764287777","https://openalex.org/W4387809776"],"abstract_inverted_index":{"308":[0],"Background:":[1],"TAPUR":[2],"is":[3,163,176,197],"a":[4,28,87,280,284,387],"phase":[5],"II":[6],"basket":[7],"study":[8],"evaluating":[9],"antitumor":[10],"activity":[11,406],"of":[12,30,82,91,119,135,147,167,191,287,298,344,350],"commercially":[13],"available":[14],"targeted":[15],"agents":[16],"in":[17,27,68,150,407,420,435],"pts":[18,31,46,149,157,169,211,235,254,261,353,385,408],"with":[19,22,32,34,40,212,276,336,409,412],"advanced":[20,410],"cancers":[21],"specific":[23],"genomic":[24],"alterations.":[25],"Results":[26],"cohort":[29,162],"EC":[33,213,411],"CDKN2A":[35,219,223,277,413],"loss":[36,220,278,414],"or":[37,108,116,222,415],"mut":[38,224,416],"treated":[39],"abemaciclib":[41,83],"are":[42,158],"reported.":[43],"Methods:":[44],"Eligible":[45],"had":[47,236,242,248,279,338,354,386],"measurable":[48],"disease,":[49],"ECOG":[50,342],"performance":[51],"status":[52],"(PS)":[53],"0-2,":[54],"adequate":[55],"organ":[56],"function,":[57],"and":[58,194,218,252,266,272,295,323,346,382,396],"no":[59],"standard":[60],"treatment":[61],"(tx)":[62],"options.":[63],"Genomic":[64],"testing":[65],"was":[66,99,309,315,326],"performed":[67],"CLIA-certified,":[69],"CAP-accredited":[70],"site":[71],"selected":[72],"labs.":[73],"Pts":[74],"received":[75],"200":[76],"mg":[77,80,93],"(four":[78],"50":[79],"tablets)":[81],"twice":[84],"daily":[85,89],"for":[86,258,264,283,417,429],"total":[88],"dose":[90],"400":[92],"until":[94],"disease":[95,100,118],"progression.":[96],"Primary":[97],"endpoint":[98],"control":[101],"(DC)":[102],"per":[103,112],"investigator":[104],"defined":[105,198],"as":[106,199],"complete":[107],"partial":[109],"(PR)":[110],"response":[111,182,192],"RECIST":[113],"v.":[114],"1.1,":[115],"stable":[117],"at":[120,359],"least":[121,360],"16":[122],"weeks":[123],"(wks)":[124],"duration":[125,190],"(SD16+).":[126],"Simon":[127],"2-stage":[128],"design":[129],"tested":[130,257],"the":[131,161,172],"null":[132,173,306],"DC":[133,174,285,307],"rate":[134,175,286,297,308],"15%":[136],"vs.":[137],"35%":[138],"(power":[139],"=":[140,143],"0.85;":[141],"\u03b1":[142],"0.10).":[144],"If":[145,165],"\u22652":[146],"10":[148,210],"stage":[151],"1":[152,240,246,274,345],"have":[153,170],"DC,":[154,171],"18":[155],"more":[156],"enrolled;":[159],"otherwise,":[160],"closed.":[164],"\u22657":[166],"28":[168],"rejected.":[177],"Secondary":[178],"endpoints":[179],"were":[180,226,255,262],"objective":[181],"(OR),":[183],"progression-free":[184],"survival":[185,188],"(PFS),":[186],"overall":[187],"(OS),":[189],"(DOR)":[193],"safety.":[195],"DOR":[196],"time":[200],"from":[201,228],"pt\u2019s":[202],"first":[203],"documented":[204],"OR":[205,296],"to":[206,231,293,303,321,332,363],"progressive":[207],"disease.":[208],"Results:":[209],"(8":[214],"adenocarcinoma,":[215,341],"2":[216,253,320,347],"squamous)":[217],"(n=5)":[221,225],"enrolled":[227],"Dec":[229],"2019":[230],"June":[232],"2022.":[233],"6":[234],"HER2":[237,243,249,339],"negative":[238,340],"EC,":[239,245,251],"pt":[241,247,270,275,335,422],"low":[244],"positive":[250],"not":[256,310,402],"HER2.":[259],"All":[260],"evaluable":[263],"efficacy":[265],"toxicity.":[267],"Table":[268],"summarizes":[269],"demographics":[271],"outcomes.":[273],"27-wk":[281],"PR":[282,337],"10%":[288,299],"(1-sided":[289],"90%":[290],"CI,":[291,301,319,330],"1%":[292],"100%)":[294],"(95%":[300,318,329],"<1%":[302],"45%).":[304],"The":[305,334],"rejected":[311],"(p=0.80).":[312],"Median":[313],"PFS":[314],"8":[316],"wks":[317,328],"13)":[322],"median":[324],"OS":[325],"17":[327],"9":[331],"35).":[333],"PS":[343],"prior":[348],"lines":[349],"therapy.":[351],"4":[352,384],"12":[355],"serious":[356],"adverse":[357],"events":[358],"possibly":[361],"related":[362],"tx,":[364],"including":[365,392,432],"anemia,":[366,393],"atrial":[367],"fibrillation,":[368],"increased":[369,394],"creatinine,":[370],"dehydration,":[371],"dyspnea,":[372],"generalized":[373],"muscle":[374],"weakness,":[375],"heart":[376],"failure,":[377],"lung":[378],"infection,":[379],"pericardial":[380],"effusion":[381],"thrombocytopenia.":[383,397],"drug-related":[388],"grade":[389],"3":[390],"AEs":[391],"bilirubin":[395],"Conclusions:":[398],"Abemaciclib":[399],"monotherapy":[400],"did":[401],"demonstrate":[403],"sufficient":[404],"clinical":[405,436],"continued":[418],"evaluation":[419],"this":[421],"population.":[423],"Other":[424],"tx":[425,433],"should":[426],"be":[427],"considered":[428],"these":[430],"pts,":[431],"offered":[434],"trials.":[437],"Clinical":[438],"trial":[439],"information:":[440],"NCT02693535":[441],".":[442],"[Table:":[443],"see":[444],"text]":[445]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2024-01-23T00:00:00"}